首页> 外国专利> ANTI-INFLAMMATION COMPOSITION FOR TREATING OR PREVENTING CHRONIC INFLAMMATION DISEASES CAUSED BY EXCESSIVE NLRP3 INFLAMMASOME ACTIVATION, BY INHIBITING ACTIVITY OF NLRP3 INFLAMMASOME, CONTAINING IL-4 OR IL-4 ACTIVATOR AND SCREENING METHOD THEREOF

ANTI-INFLAMMATION COMPOSITION FOR TREATING OR PREVENTING CHRONIC INFLAMMATION DISEASES CAUSED BY EXCESSIVE NLRP3 INFLAMMASOME ACTIVATION, BY INHIBITING ACTIVITY OF NLRP3 INFLAMMASOME, CONTAINING IL-4 OR IL-4 ACTIVATOR AND SCREENING METHOD THEREOF

机译:通过抑制包含IL-4或IL-4活化剂的NLRP3炎症反应活性和治疗方法,治疗或预防由过量的NLRP3炎症反应活化引起的慢性炎症疾病的抗炎组合物

摘要

The present invention relates to an anti-inflammatory composition for treating or preventing chronic inflammatory diseases caused by excessive activities of NLRP3 inflammasome, by inhibiting the activities of the NLRP3 inflammasome of macrophages, comprising IL-4 or an IL-4 activator, and relates to a screening method thereof. According to the present invention, the anti-inflammatory composition has excellent effects in treating or alleviating inflammation, thereby being broadly used as a therapeutic agent for inflammation or a supplementary food for health comprising the same as an active ingredient. According to the present invention, the screening method can be efficiently used for developing the therapeutic agent for inflammation and for studying the mechanism of IL-4 action.
机译:本发明涉及通过抑制巨噬细胞的NLRP3炎性体的活性来治疗或预防由NLRP3炎性体的过度活性引起的慢性炎性疾病的抗炎组合物,其包含IL-4或IL-4活化剂。其筛选方法。根据本发明,抗炎组合物在治疗或减轻炎症方面具有优异的效果,因此被广泛用作炎症的治疗剂或包含其作为活性成分的健康补充食品。根据本发明,该筛选方法可以有效地用于开发炎症治疗剂和研究IL-4作用的机理。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号